Zobrazeno 1 - 6
of 6
pro vyhledávání: '"V Yu Lizhdvoy"'
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 1, Pp 7-12 (2020)
Background: Robotic mechanotherapy is considered as a promising area of physical rehabilitation of multiple sclerosis patients, while it ensures high training efficacy. Aim: To study the effect of physical training using with the ExoAtlet exoskeleton
Externí odkaz:
https://doaj.org/article/66c9d004ed044fec937cd2480744e521
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 3, Pp 317-323 (2016)
Background: Neutralizing antibodies (NAbs) affect the effectiveness of interferon therapy in patients with multiple sclerosis; however, this influence cannot be considered as unequivocal. NAbs formation is determined by several factors, such as frequ
Externí odkaz:
https://doaj.org/article/8d705042086245b195074ed7eddce54f
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 1, Pp 7-12 (2020)
Background: Robotic mechanotherapy is considered as a promising area of physical rehabilitation of multiple sclerosis patients, while it ensures high training efficacy. Aim: To study the effect of physical training using with the ExoAtlet exoskeleton
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(7)
To study an effect of robotic mechanotherapy on the functional condition of patients with multiple sclerosis (MS) with impaired walking function using the ExoAtlet exoskeleton.A prospective open-source, uncontrolled, single-center study included 44 p
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 119(2. Vyp. 2)
The two-year study of the efficacy of Ifnb-1B (infibeta) in patients with relapsing-remitting (RRS) and secondary progressive multiple sclerosis (SPMS) in the Moscow region with the criteria NEDA-3.Three hundred patients, 81 men and 219 women, aged f
Autor:
F. A. Khabirov, O. V. Trifonova, T. O. Simaniv, Yu. V. Trinitatsky, L. A. Aver’yanova, A. I. Sergeeva, S. N. Sharanova, E. V. Granatov, T I Iakushina, N. N. Babicheva, D V Sazonov, L. A. Tsukurova, A N Boyko, N. Yu. Lashch, O. E. Gur’yanova, Kotov Sv, Roman Ivanov, Yu A Belova, Odinak Mm, E. V. Lysogorskaya, M. N. Zakharova, V Yu Lizhdvoy, M. S. Shustova, T I Khaibullin
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(10 Pt 2)
The article presents the results of international multicenter randomized double-blind, active and placebo-controlled, comparative phase 3 trial. The goal of the study was to demonstrate non-inferiority of BCD-063 (glatiramer acetate, manufactured by